Log In
Print
BCIQ
Print
Print this Print this
 

ASP3291

  Manage Alerts
Collapse Summary General Information
Company Telsar Pharma Inc.
DescriptionMelanocortin (MC) receptor agonist
Molecular Target Melanocortin (MC) receptor
Mechanism of ActionMelanocortin 1 receptor (MC1R) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation

Partner

Drais Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today